ES8603449A1 - Proceso para preparar un derivado de piperazina - Google Patents

Proceso para preparar un derivado de piperazina

Info

Publication number
ES8603449A1
ES8603449A1 ES85543397A ES543397A ES8603449A1 ES 8603449 A1 ES8603449 A1 ES 8603449A1 ES 85543397 A ES85543397 A ES 85543397A ES 543397 A ES543397 A ES 543397A ES 8603449 A1 ES8603449 A1 ES 8603449A1
Authority
ES
Spain
Prior art keywords
carbon atoms
group containing
diphenylmethylpiperazinyl
salts
cerebral circulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES85543397A
Other languages
English (en)
Other versions
ES543397A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Publication of ES543397A0 publication Critical patent/ES543397A0/es
Publication of ES8603449A1 publication Critical patent/ES8603449A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCESO PARA PREPARAR UN DERIVADO DE PIPERAZINA. COMPRENDE HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA R8-X, PARA OBTENER DERIVADOS DE PIPERAZINA DE FORMULA (I) DONDE R1 ES UN ATOMO DE H, O UN GRUPO BAJO EN ALQUILO; R2 ES UN GRUPO ARALQUILOXILO, UN GRUPO BAJO EN ALCOXILO CON C 1 A 5 U OTROS; R3 ES UN ATOMO DE H, O UN GRUPO ARALQUILOXILO U OTROS; R4 ES UN ATOMO DE H O UN GRUPO BAJO EN ALCOXILO CON C 1 A 5, A CONDICION DE QUE R2 SEA UN GRUPO DISTINTO AL GRUPO BAJO EN ALCOXILO CON C 1 A 5 CUANDO R3 Y R4 SON ATIMOS DE HIDROGENO. LA REACCION SE REALIZA EN UN SOLVENTE COMO ETER DE TETRAHIDROFURANO, ALCOHOLES COMO METANOL Y ETANOL, A TEMPERATURA DESDE 0JC HASTA LA DE EBULLICION DEL DISOLVENTE EMPLEADO Y DURANTE 24 HORAS. TIENEN APLICACIONES FARMACEUTICAS PARA FORMAR PARTE DE COMPUESTOS QUE MEJORAN LA CIRCULACION CEREBRAL.
ES85543397A 1982-12-02 1985-05-22 Proceso para preparar un derivado de piperazina Expired ES8603449A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57212036A JPS59101475A (ja) 1982-12-02 1982-12-02 新規ピペラジン誘導体およびその製造法ならびにこれを含有する脳循環改善剤

Publications (2)

Publication Number Publication Date
ES543397A0 ES543397A0 (es) 1986-01-01
ES8603449A1 true ES8603449A1 (es) 1986-01-01

Family

ID=16615802

Family Applications (2)

Application Number Title Priority Date Filing Date
ES83524283A Expired ES8604911A1 (es) 1982-12-02 1983-07-20 Proceso para preparar un derivado de piperazina.
ES85543397A Expired ES8603449A1 (es) 1982-12-02 1985-05-22 Proceso para preparar un derivado de piperazina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES83524283A Expired ES8604911A1 (es) 1982-12-02 1983-07-20 Proceso para preparar un derivado de piperazina.

Country Status (11)

Country Link
US (1) US4528194A (es)
JP (1) JPS59101475A (es)
KR (1) KR900003277B1 (es)
BR (1) BR8304319A (es)
CH (1) CH655719A5 (es)
DE (1) DE3326148A1 (es)
ES (2) ES8604911A1 (es)
FR (1) FR2541275B1 (es)
GB (2) GB8318683D0 (es)
IT (1) IT1162913B (es)
SE (1) SE464707B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3424685A1 (de) * 1984-07-05 1986-02-06 Beiersdorf Ag, 2000 Hamburg Neue substituierte phenylpiperazinyl-propanole, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JPS61161272A (ja) * 1985-01-11 1986-07-21 Kanebo Ltd 新規なピペラジン誘導体および該化合物を有効成分とする医薬組成物
JPH08776B2 (ja) * 1986-08-20 1996-01-10 日本ケミフア株式会社 脳細胞保護作用を有する医薬組成物
EP0354068B1 (en) * 1988-08-05 1994-06-15 Nippon Chemiphar Co., Ltd. Optically active piperazine derivative
JP2679872B2 (ja) * 1989-04-28 1997-11-19 明治製菓株式会社 Ｎ−置換ピペラジン誘導体を含む脳機能障害改善剤
WO1990013539A1 (en) * 1989-04-28 1990-11-15 Meiji Seika Kaisha, Ltd. New n-substituted piperazine derivatives and drug for improving functional disorder of brain
DE4108527A1 (de) * 1991-03-15 1992-09-17 Basf Ag Neue 1-(4-cyano-4-aryl-cyclohexyl)piperazine, ihre herstellung und verwendung
DE4404249C2 (de) * 1994-02-10 2001-10-18 Basf Ag Substituierte Cycloalkyl-piperazinyl-ethanol, ihre Herstellung und diese enthaltende Arzneimittel
KR100472086B1 (ko) * 2001-11-23 2005-02-21 한국화학연구원 항산화 활성을 갖는 3,5-디알콕시-4-히드록시페닐기로치환된 피페라진 유도체, 그의 제조방법 및 이를 포함하는약학적 조성물
US8186436B2 (en) * 2009-09-10 2012-05-29 Warren Carlos Thermal insulating packer fluid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131192C (es) * 1965-06-16
FR2081579B1 (es) * 1970-03-18 1973-04-06 Delalande Sa
FR2163358A1 (en) * 1971-12-15 1973-07-27 Synthelabo Phenylalkanolamine derivs - with effects on the smooth musculature
NL7306771A (es) * 1972-06-02 1973-12-04
JPS504087A (es) * 1973-05-17 1975-01-16

Also Published As

Publication number Publication date
GB2131016A (en) 1984-06-13
ES543397A0 (es) 1986-01-01
KR840006983A (ko) 1984-12-04
CH655719A5 (fr) 1986-05-15
IT1162913B (it) 1987-04-01
FR2541275A1 (fr) 1984-08-24
SE8304071L (sv) 1984-06-03
GB2131016B (en) 1985-11-20
US4528194A (en) 1985-07-09
GB8318683D0 (en) 1983-08-10
ES8604911A1 (es) 1986-03-16
JPH0254832B2 (es) 1990-11-22
KR900003277B1 (ko) 1990-05-12
ES524283A0 (es) 1986-03-16
DE3326148A1 (de) 1984-06-07
DE3326148C2 (es) 1989-11-16
SE8304071D0 (sv) 1983-07-20
IT8367776A0 (it) 1983-07-19
GB8319317D0 (en) 1983-08-17
BR8304319A (pt) 1984-11-06
JPS59101475A (ja) 1984-06-12
SE464707B (sv) 1991-06-03
FR2541275B1 (fr) 1986-02-07

Similar Documents

Publication Publication Date Title
ES8301962A1 (es) Un procedimiento para la produccion de un derivado de carboslivilo.
ES8607287A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
ES2000185A6 (es) Procedimiento para preparar derivados de acidos piridoncaboxilicos
PT71940A (en) Process for preparing morpholine derivatives
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES8604911A1 (es) Proceso para preparar un derivado de piperazina.
ES8106302A1 (es) Un procedimiento para la preparacion de derivados de acido trans-(4-oxo-4h-quinazolin-3-il)-2-propenoico
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES486824A1 (es) Procedimiento para la preparacion de nuevos derivados de 4- (naftilmetil) piperidinas
ES8103756A1 (es) Un procedimiento para preparar compuestos de cefem
ES8301224A1 (es) Procedimiento para la preparacion de nuevas 5,10-dihidro -11h-dibenzo b,e 1,4 diazepin-11-onas, sustituidas en posi- cion 5
YU196082A (en) Process for preparing new heterocyclic compounds
ES8701156A1 (es) Un procedimiento para producir un derivado de 2-(3,5-dial- quil-4-hidroxifenil)indol
ES8303398A1 (es) Un procedimiento para la preparacion de un derivado de 2-piridincarboxamida.
ES8500953A1 (es) Procedimiento para preparar derivados de tieno-tiazol
ES8200113A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
ES8400743A1 (es) "procedimiento para la preparacion de compuestos de 1-fenilindazol-3-ona".
ES8201140A1 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli nas-(2)sustituidas.
ES8401761A1 (es) Un procedimiento para la preparacion de derivados de 1-(3,4,5-trimetoxicinamoil)-4-aminocarboniletil-piperazina sustituidos.
ES8301888A1 (es) "procedimiento para la preparacion de derivados de fenoxi-aminopropanol substituidos" como divisional de la patente de invencion n 502.649 del 1 junio 1981.
IE801382L (en) Piperidines.
ES8405020A1 (es) Un procedimiento para la preparacion de derivados de fosfolipidos.
YU216483A (en) Process for preparing new semicarbazides